Home›Companies›Biotech & Pharma›Biostate AI

Biostate AI, Inc

Updated Oct 27, 2026·Latest SEC filing May 12, 2025·Suggest an edit

About Biostate AI

Biostate AI is a private company based in Houston, Texas, incorporated in 2023 in Delaware. It has reported $5,178,899 raised in two offerings on Form D since August 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 29, 2025May 12, 2025$4,178,899of $13.0M target7$596KEquity, Securities on exerciseRule 506(b)Form D ↗
Aug 10, 2023Aug 23, 2023$1,000,000of $14.0M target1$1.0MEquity, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$5,178,899

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Biostate AI's Form D filed May 12, 2025.

EM
Eva Miao
Treasurer
AG
Ashwin Gopinath
Executive officer and director
DZ
David Zhang
Executive officer and director
Also a president and director at Pupil Bio and an executive officer, director and promoter at Matrix Partners China.

Sources

  1. SECBiostate AI, Inc filing history